RARubina Ahmed

Rubina Ahmed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rubina Ahmed has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrated phytochemical, biological and structure-based in silico evaluation of the thyroid modulatory potential of Kaji Nemu (Citrus limon (L.) Osbeck) from Assam

    by R Yashmin, R Ahmed, S Y Jyoti, J C Kalita

    Kaji Nemu (Citrus limon (L.) Osbeck), a unique citrus from Northeast India with extensive nutritional and therapeutic attributes, has been declared the state fruit of Assam and a geographical indication-certified commodity. Despite its known therapeutic activity, this study highlights the phytochemical potential of the methanolic peel extract of Kaji Nemu and its modulatory effects on thyroid-related pathways. The extraction yield was 10.39 %. Qualitative analysis detected tannins, alkaloids, phenols, saponins, flavonoids, terpenoids and carbohydrates. Quantitative analysis further showed that the extract contained 18.03 mg/g of total phenols, 2.25 mg/g of total flavonoids and 19.52 mg/g of total tannins. The antioxidant activity assay results showed an IC50 of 42.00 µg/mL in the DPPH assay, alongside strong FRAP and ABTS scavenging activities. The extract demonstrated cytotoxicity against HEK293 cells in the MTT assay, with an IC50 value of 177.7 µg/mL. Gas chromatography-mass spectrometry (GC-MS) analysis identified 93 phytochemicals in the extract and reported antioxidant, anti-inflammatory, anticancer and antithyroid activities. Virtual screening and molecular docking against the thyroid hormone receptor beta 1 (TRβ1) identified 3-tert-Butyl-4-hydroxyanisole, detected through GC-MS analysis, as the lead compound. It showed a strong binding affinity (-6.7 kcal/mol), which was higher than that of the reference antithyroid drug methimazole. HPLC analysis quantified vitamin E and C at 0.09 and 23.97 mg/mL, respectively, supporting its nutritional and functional value. ICP-MS mineral profiling identified sodium as the most abundant element (18.85 mg/L), followed by potassium, calcium and zinc. The study highlights the translational potential of underutilised citrus as safe, novel and effective candidates for thyroid-related treatment, meriting further mechanistic and in vivo studies.

  • Phytochemical Insights into Citrus limon (L.) Osbeck (Kaji Nemu) of Assam as a Potential Natural Modulator of Hyperthyroidism: A Structure-Based and Experimental Approach

    by Raihana Yashmin, Rubina Ahmed, Taslema Begum, Jogen Chandra Kalita, Akan Das, Himakshi Sarma

    Hyperthyroidism is characterized by impaired hormone biosynthesis and dysregulated receptor signaling, and remains a pressing clinical concern as current drugs such as methimazole are often associated with adverse effects and limited efficacy. In this study, we explored the methanolic peel extract of Citrus limon (L.) Osbeck (Kaji Nemu), a distinctive citrus variety from Northeast India, is a potential source of natural therapeutic compounds. LC-MS profiling identified 55 phytochemicals, of which 27 drug-like candidates were shortlisted, alongside ADMET evaluations. Molecular docking revealed three lead compounds including 1-(3,4-Dimethylphenyl)-4-[(4-isopropylphenyl)sulfonyl]piperazine, 2 Benzylcyclohexanol and 2-[(1Z)-2-Methoxy-1-propenyl]-1,3,5-trimethylbenzene showing superior binding affinities with thyroid peroxidase (TPO: –8.2 kcal/mol), thyroid receptor [ ] (TR[ ]: –7.6 kcal/mol) and thyroid receptor [ ]1 (TR[ ]1: –7.7 kcal/mol), respectively, compared to methimazole. A detailed interaction analysis demonstrated extensive hydrogen bonding, hydrophobic, and [ ]-interactions, suggesting stable and versatile engagement within binding pockets. Molecular dynamics simulations further confirmed the protein-specific stabilizing effects of candidate ligands, with notable enhancement of backbone stability in TPO and TR[ ]1. ELISA-based enzyme quantification further supported the therapeutic relevance, with Kaji Nemu peel extract significantly reducing TPO levels in hyperthyroid tissue samples. Overall, the study highlights the translational potential of Kaji Nemu phytochemicals as multi-target modulators capable of simultaneously inhibiting thyroid hormone biosynthesis and regulating receptor activity. These findings position this indigenous citrus resource as a promising avenue for developing safer, plant-derived interventions for managing hyperthyroidism, paving the way for further in vitro and in vivo validations.

  • Open Access

    In Vivo Study on the Therapeutic Potential of Nothapodytes nimmoniana (J. Graham) Mabb. in DHEA-induced Polycystic Ovary Syndrome in Female Albino Mice

    by Rubina Ahmed, Rahul Sarma, Nibedita Talukdar, Sanjana Sharmin, Jogen Chandra Kalita

    Background: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, characterised by elevated androgen levels, chronic inflammation, and oxidative stress. Conventional therapies for PCOS, such as hormonal drugs and insulin sensitisers, often pose side effects and may not fully address the complex nature of the disorder. In recent years, there has been a growing interest in herbal medicine as a safer and more holistic alternative. Aim: The present study aims to evaluate the therapeutic potential of Nothapodytes nimmoniana methanolic leaf extract in the management of PCOS induced by Dehydroepiandrosterone (DHEA) in female albino mice, with a focus on its impact on reproductive, hormonal, and histopathological parameters. Methods: The investigation focused on the effects of its methanolic leaf extract of N. nimmoniana (MLENN), a medicinal plant of significant ethnobotanical value, on hormonal balance, antioxidant status, and the histoarchitecture of ovarian and uterine tissues in a DHEA-induced PCOS mice model. Female albino mice received MLENN at 200 and 400 mg/kg body weight for 20 days, with clomiphene citrate as the standard drug. Hormonal levels (LH, FSH, estrogen, progesterone, testosterone), antioxidant enzymes (SOD, CAT, GPX) and tissue morphology were assessed using histological and Scanning Electron Microscopy (SEM) techniques. Results: This study highlights the potential of N. nimmoniana as a promising natural resource for addressing PCOS through a multi-pronged approach involving significant reduction in serum LH, estrogen, and testosterone levels while increasing FSH and progesterone (p<0.05). PCOS-induced mice showed restored oestrous cyclicity and enhanced antioxidant activity (SOD, CAT, GPX). Histological and SEM analyses revealed reduced cyst formation, thinner theca layers, increased corpora lutea, thicker granulosa layers, and normalisation of uterine histoarchitecture. The 400 mg/kg MLENN dose showed the most pronounced therapeutic effects in all the experimental parameters. Major Findings: This is the first report demonstrating the efficacy of MLENN in ameliorating PCOS symptoms in mice. The methanolic extract of N. nimmoniana, particularly at 400 mg/kg, significantly improves hormonal profile, oxidative stress markers, and reproductive tissue structure, indicating its potential as a natural therapeutic agent for PCOS.

  • An Integrated Systematic Study Combining GC–MS, HPLC, Molecular Docking, and MD Simulation to Explore the Potential of Nothapodytes nimmoniana (J. Graham) Mabb. for the Management of PCOS

    by Rubina Ahmed, Raihana Yashmin, Jogen Chandra Kalita, Himakshi Sarma, Akan Das

    Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by hormonal imbalance, insulin resistance, and chronic inflammation, often leading to infertility and metabolic complications. This study explores the therapeutic potential of Nothapodytes nimmoniana , an ethnobotanically significant plant, for PCOS management. Methanolic leaf extracts of the plant were analyzed using GC–MS and HPLC, revealing the presence of several bioactive compounds, including vitamins D and E. These vitamins are well‐documented for their roles in improving insulin sensitivity, regulating hormonal levels, and reducing oxidative stress, making them valuable in alleviating PCOS symptoms. Through virtual screening and molecular docking, 4,4,5,8‐tetramethyl‐2,3‐dihydrochromen‐2‐ol was identified as a promising candidate with strong binding affinities to tumor necrosis factor‐alpha (TNF‐α) and human estrogenic receptor‐α (hER‐α), two key proteins implicated in PCOS pathogenesis. Molecular dynamics simulations further confirmed the stability and favorable interactions of this compound with the target proteins, indicating its potential as a lead molecule for drug development. The study highlights N. nimmoniana's pharmacological significance, emphasizing its anti‐inflammatory, antioxidant, and therapeutic properties. Integrating computational and experimental approaches, it provides a foundation for PCOS treatment. Future in vivo and clinical studies are needed to validate its efficacy and safety, promoting plant‐derived compounds for innovative, sustainable therapies.